Clinical trial
Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes (CIT-03)
NCT00434850 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes (CIT-03)
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- November 30, 2013
- Enrollment
- 14 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.